Detalhe da pesquisa
1.
Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors.
J Pharmacol Exp Ther
; 382(1): 31-43, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489782
2.
Pharmacodynamic model of slow reversible binding and its applications in pharmacokinetic/pharmacodynamic modeling: review and tutorial.
J Pharmacokinet Pharmacodyn
; 49(5): 493-510, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040645
3.
A quantitative systems pharmacology model of hyporesponsiveness to erythropoietin in rats.
J Pharmacokinet Pharmacodyn
; 48(5): 687-710, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100188
4.
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women.
J Pharmacokinet Pharmacodyn
; 48(2): 261-272, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389521
5.
Delay differential equations based models in NONMEM.
J Pharmacokinet Pharmacodyn
; 48(6): 763-802, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302262
6.
Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women.
J Pharmacokinet Pharmacodyn
; 48(3): 411-438, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954911
7.
Ordinary differential equation approximation of gamma distributed delay model.
J Pharmacokinet Pharmacodyn
; 46(1): 53-63, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617672
8.
Indirect pharmacodynamic models for responses with circadian removal.
J Pharmacokinet Pharmacodyn
; 46(1): 89-101, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694437
9.
Evaluation of performance of distributed delay model for chemotherapy-induced myelosuppression.
J Pharmacokinet Pharmacodyn
; 45(2): 329-337, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435950
10.
Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients.
J Pharmacokinet Pharmacodyn
; 45(2): 277-284, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290034
11.
Age-structured population model of cell survival.
J Pharmacokinet Pharmacodyn
; 44(4): 305-316, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28357630
12.
FG-3019, a Human Monoclonal Antibody Recognizing Connective Tissue Growth Factor, is Subject to Target-Mediated Drug Disposition.
Pharm Res
; 33(8): 1833-49, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059922
13.
Special issue: chronopharmacometrics.
J Pharmacokinet Pharmacodyn
; 48(3): 319-320, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963472
14.
A cell-level model of pharmacodynamics-mediated drug disposition.
J Pharmacokinet Pharmacodyn
; 43(5): 513-27, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612462
15.
Pharmacodynamic models of age-structured cell populations.
J Pharmacokinet Pharmacodyn
; 42(5): 573-89, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377617
16.
Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
J Pharmacokinet Pharmacodyn
; 42(6): 709-20, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341875
17.
Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations.
J Pharmacokinet Pharmacodyn
; 41(4): 291-318, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142056
18.
The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
Biopharm Drug Dispos
; 35(6): 330-40, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24888906
19.
Pharmacodynamic Age Structured Population Model For Cell Trafficking.
J Pharm Sci
; 113(1): 257-267, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926235
20.
Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness.
Pharm Res
; 30(4): 1026-36, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23187865